Stock ARJO B ARJO AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Arjo AB

Equities

ARJO B

SE0010468116

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe
Other stock markets
 15:40:42 26/06/2024 BST 		5-day change 1st Jan Change
40.82 SEK -3.27% Intraday chart for Arjo AB -3.35% +3.91%
05-16 Transcript : Arjo AB - Special Call
05-16 Arjo Provides Sales Guidance for the Year 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 12,273 17,118 30,179 10,606 10,731 11,494 - -
Enterprise Value (EV) 1 18,176 22,185 34,520 15,650 15,051 15,689 15,215 14,641
P/E ratio 30.4 x 32.6 x 40.7 x 23.7 x 22.4 x 18.6 x 14.8 x 12.8 x
Yield 1.44% 1.35% 1.04% 2.18% 2.28% 2.56% 2.98% 3.64%
Capitalization / Revenue 1.38 x 1.89 x 3.33 x 1.06 x 0.98 x 1.01 x 0.97 x 0.93 x
EV / Revenue 2.04 x 2.44 x 3.81 x 1.57 x 1.37 x 1.38 x 1.28 x 1.18 x
EV / EBITDA 10.5 x 11.6 x 16.7 x 8.5 x 7.46 x 7.4 x 6.53 x 5.89 x
EV / FCF 40.3 x 15 x 32.6 x 447 x 10.3 x 16.9 x 14.6 x 12.7 x
FCF Yield 2.48% 6.68% 3.07% 0.22% 9.68% 5.93% 6.85% 7.87%
Price to Book 2.08 x 3.04 x 4.38 x 1.39 x 1.42 x 1.41 x 1.33 x 1.25 x
Nbr of stocks (in thousands) 272,370 272,370 272,370 272,370 272,370 272,370 - -
Reference price 2 45.06 62.85 110.8 38.94 39.40 42.20 42.20 42.20
Announcement Date 04/02/20 03/02/21 03/02/22 25/01/23 30/01/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 8,925 9,078 9,070 9,979 10,980 11,408 11,894 12,356
EBITDA 1 1,728 1,913 2,072 1,841 2,017 2,121 2,331 2,484
EBIT 1 724 943 1,116 765 957 1,063 1,261 1,415
Operating Margin 8.11% 10.39% 12.3% 7.67% 8.72% 9.31% 10.6% 11.45%
Earnings before Tax (EBT) 1 542 702 989 597 640 827 1,038 1,200
Net income 1 403 526 742 447 480 619.5 774 896.5
Net margin 4.52% 5.79% 8.18% 4.48% 4.37% 5.43% 6.51% 7.26%
EPS 2 1.480 1.930 2.720 1.640 1.760 2.275 2.842 3.292
Free Cash Flow 1 451 1,483 1,059 35 1,457 930.5 1,042 1,153
FCF margin 5.05% 16.34% 11.68% 0.35% 13.27% 8.16% 8.76% 9.33%
FCF Conversion (EBITDA) 26.1% 77.52% 51.11% 1.9% 72.24% 43.86% 44.68% 46.41%
FCF Conversion (Net income) 111.91% 281.94% 142.72% 7.83% 303.54% 150.2% 134.57% 128.61%
Dividend per Share 2 0.6500 0.8500 1.150 0.8500 0.9000 1.082 1.258 1.535
Announcement Date 04/02/20 03/02/21 03/02/22 25/01/23 30/01/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 2,456 2,370 2,404 2,519 2,686 2,638 2,686 2,777 2,879 2,759 2,811 2,851 3,004 2,880 2,928
EBITDA 1 541 490 430 420 500 474 490 504 614 502 495.1 499.6 625.2 551 565
EBIT 1 301 237 165 140 216 196 206 207 342 219 234.5 238.1 362 289 303
Operating Margin 12.26% 10% 6.86% 5.56% 8.04% 7.43% 7.67% 7.45% 11.88% 7.94% 8.34% 8.35% 12.05% 10.03% 10.35%
Earnings before Tax (EBT) 1 254 218 139 115 124 126 135 130 242 175 171.3 182.9 299 249 268
Net income 1 190 164 104 86 93 95 102 98 181 132 126.4 133.1 228.4 186 200
Net margin 7.74% 6.92% 4.33% 3.41% 3.46% 3.6% 3.8% 3.53% 6.29% 4.78% 4.5% 4.67% 7.6% 6.46% 6.83%
EPS 2 0.7000 0.6000 0.3800 0.3200 0.3400 0.3500 0.3700 0.3600 0.6700 0.4800 0.4638 0.4902 0.8386 0.6800 0.7300
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 03/02/22 22/04/22 14/07/22 28/10/22 25/01/23 20/04/23 14/07/23 19/10/23 30/01/24 18/04/24 - - - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 5,903 5,067 4,341 5,044 4,320 4,195 3,721 3,147
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.416 x 2.649 x 2.095 x 2.74 x 2.142 x 1.977 x 1.596 x 1.267 x
Free Cash Flow 1 451 1,483 1,059 35 1,457 931 1,042 1,153
ROE (net income / shareholders' equity) 7.1% 9.1% 11.9% 6.2% 6.39% 8.36% 9.59% 10.5%
ROA (Net income/ Total Assets) 2.92% 3.7% 5.21% 2.9% 3.06% 4.3% 5.7% 6.8%
Assets 1 13,779 14,216 14,234 15,389 15,705 14,407 13,579 13,184
Book Value Per Share 2 21.70 20.70 25.30 28.00 27.80 30.00 31.70 33.80
Cash Flow per Share 2 - - 6.380 - 7.570 4.600 5.600 5.900
Capex 1 729 784 675 880 604 725 770 790
Capex / Sales 8.17% 8.64% 7.44% 8.82% 5.5% 6.35% 6.47% 6.4%
Announcement Date 04/02/20 03/02/21 03/02/22 25/01/23 30/01/24 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Arjo AB

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
42.2 SEK
Average target price
51.25 SEK
Spread / Average Target
+21.45%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ARJO AB Stock Arjo AB
+3.91% 1.09B
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.00% 184B
MEDTRONIC PLC Stock Medtronic plc
-3.73% 103B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.87% 67.59B
CENCORA, INC. Stock Cencora, Inc.
+15.08% 46.93B
DEXCOM, INC. Stock DexCom, Inc.
-9.63% 43.87B
HOYA CORPORATION Stock Hoya Corporation
+8.28% 41.2B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+17.19% 30.47B
TERUMO CORPORATION Stock Terumo Corporation
+13.59% 24.16B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-7.88% 23.57B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. ARJO B Stock
  4. Financials Arjo AB